# Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

> **NCT01412164** · NA · COMPLETED · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 730 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** FIREHAWK biodegradable polymer rapamycin-eluting stent

## Key facts

- **NCT ID:** NCT01412164
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-02
- **Final completion:** 2017-01
- **Target enrollment:** 730 (ACTUAL)
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01412164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01412164, "Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01412164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*